EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Adjunctive Thrombolytics After Successful Endovascular Reperfusion: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Mohamed F Doheim iD, Mahmoud H Mohammaden iD, Ammar Jumah, Qingwu Yang iD, Wenjie Zi iD, Yangmei Chen, Yamei Tang iD, Yajie Liu, Xiaochuan Huo, Liping Liu, Bernard Yan, Zhongrong Miao und 9 weitere

Annals of Neurology · 2025-12 · 98 (6) · 1299-1314

DOI: 10.1002/ana.70021 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Annals of Neurology, online erschienen am 13.08.2025. Verfasst von Mohamed F Doheim und 20 weiteren Autor:innen. Beteiligte Einrichtung: UPMC Stroke Institute, Department of Neurology and Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: Fibrinolytic Agents, Endovascular Procedures, Thrombolytic Therapy, Thrombectomy. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The efficacy and safety of intra‐arterial thrombolysis (IAT) as an adjunct to endovascular thrombectomy (EVT) in large vessel occlusion strokes (LVOS) remain uncertain, with recent randomized controlled trials (RCTs) yielding conflicting results. This meta‐analysis aimed to assess the impact of IAT following successful EVT in patients with LVOS.

Methods

A comprehensive search was conducted across PubMed, ClinicalTrials.gov , the Cochrane Library databases, and the International Stroke Conference 2025 abstracts to identify RCTs evaluating IAT following successful EVT from January 2015 to February 2025. The primary outcome was the odds of achieving an excellent functional outcome (defined as a modified Rankin Scale [mRS] = 0–1 at 90 days). Secondary outcomes included 90‐day functional independence (mRS = 0–2). Safety measures included symptomatic intracranial hemorrhage (sICH), and mortality at 90 days. The protocol was registered in PROSPERO (CRD420250651602).

Results

The primary pooled analysis of 6 RCTs ( N = 1,974) showed that IAT significantly increased the likelihood of achieving excellent functional outcome at 90 days (mRS = 0–1: odds ratio [OR] = 1.47, 95% confidence interval [CI] = 1.21–1.80, p < 0.001), with a notable effect in anterior circulation (OR = 1.48, 95% CI = 1.18–1.87, p < 0.001) but not in posterior circulation LVOS (OR = 1.51, 95% CI = 0.83–2.74, p = 0.18). Among thrombolytic drugs, alteplase was most strongly associated with favorable outcomes (mRS = 0–1: OR = 1.94, 95% CI = 1.31–2.87, p < 0.001), followed by tenecteplase (OR = 1.43, 95% CI = 1.08–1.89, p = 0.01). No significant safety concerns were observed, as there was no increase in the odds of sICH (OR = 1.15, 95% CI = 0.75–1.75, p = 0.51) or 90‐day mortality (OR = 1.00, 95% CI = 0.79–1.26, p = 0.99). Sensitivity analyses for all outcomes yielded consistent results.

Interpretation

IAT following successful EVT significantly enhances the likelihood of achieving an excellent functional outcome, particularly in anterior circulation strokes. Although the benefit in posterior circulation strokes remains uncertain, the lack of significant differences in sICH risk and mortality across thrombolytic drugs and stroke locations support the safety of IAT. ANN NEUROL 2025;98:1299–1314

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibrinolytic AgentsEndovascular ProceduresThrombolytic TherapyThrombectomyIschemic StrokeReperfusionHumansRandomized Controlled Trials as TopicTreatment OutcomeCombined Modality TherapyTissue Plasminogen Activator

Substanzen

Fibrinolytic AgentsTissue Plasminogen Activator

Autor:innen und Institutionen

  • UPMC Stroke Institute, Department of Neurology and Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Department of Neurology, Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA, USA.
  • Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, People's Republic of China.
  • Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Yuzhong District, People's Republic of China.
  • Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Department of Neurology, Shenzhen Hospital of Southern Medical University, Shenzhen, People's Republic of China.

ORCID-Profile: Mohamed F Doheim, Mahmoud H Mohammaden, Qingwu Yang, Wenjie Zi, Yamei Tang, Liqun Jiao

Zitieren

APA

Doheim, M. F., Mohammaden, M. H., Jumah, A., Yang, Q., Zi, W., Chen, Y., Tang, Y., Liu, Y., Huo, X., Liu, L., Yan, B., Miao, Z., Hu, W., Tao, C., Liu, X., Jiao, L., Bai, X., Chen, W., Haussen, D. C., …, & Nogueira, R. G. (2025). Adjunctive Thrombolytics After Successful Endovascular Reperfusion: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Annals of Neurology, 98(6), 1299-1314. https://doi.org/10.1002/ana.70021

Vancouver

Doheim MF, Mohammaden MH, Jumah A, Yang Q, Zi W, Chen Y, et al. Adjunctive Thrombolytics After Successful Endovascular Reperfusion: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Annals of Neurology. 2025;98(6):1299-1314. doi:10.1002/ana.70021

BibTeX
@article{Doheim2025,
  author = {Doheim, Mohamed F and Mohammaden, Mahmoud H and Jumah, Ammar and Yang, Qingwu and Zi, Wenjie and Chen, Yangmei and Tang, Yamei and Liu, Yajie and Huo, Xiaochuan and Liu, Liping and Yan, Bernard and Miao, Zhongrong and Hu, Wei and Tao, Chunrong and Liu, Xinfeng and Jiao, Liqun and Bai, Xuesong and Chen, Wenhuo and Haussen, Diogo C and Nguyen, Thanh and Nogueira, Raul G},
  title = {Adjunctive Thrombolytics After Successful Endovascular Reperfusion: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials},
  journal = {Annals of Neurology},
  year = {2025},
  volume = {98},
  number = {6},
  pages = {1299--1314},
  doi = {10.1002/ana.70021}
}
Kostenlos starten →